ArticleMolecular therapy oncolytics2020

Dual Inhibition of MAPK and JAK2/STAT3 Pathways Is Critical for the Treatment of BRAF Mutant Melanoma.

Kun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.